Hookipa Pharma reports Q2 EPS ($1.52), consensus ($1.25)
PremiumThe FlyHookipa Pharma reports Q2 EPS ($1.52), consensus ($1.25)
1M ago
HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Premium
Press Releases
HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights
1M ago
Hookipa Pharma Announces Executive Reshuffle and Board Enhancements
Premium
Company Announcements
Hookipa Pharma Announces Executive Reshuffle and Board Enhancements
2M ago
Upcoming Stock Splits This Week (July 8 to July 12)
PremiumMarket NewsUpcoming Stock Splits This Week (July 8 to July 12)
2M ago
JMP Securities healthcare analysts hold an analyst/industry conference call
Premium
The Fly
JMP Securities healthcare analysts hold an analyst/industry conference call
2M ago
Hookipa Pharma announces 1-for-10 reverse stock split
Premium
The Fly
Hookipa Pharma announces 1-for-10 reverse stock split
2M ago
Hookipa Pharma’s HB-200 Shows Promise in Phase 2 Cancer Trial
PremiumCompany AnnouncementsHookipa Pharma’s HB-200 Shows Promise in Phase 2 Cancer Trial
4M ago
Hookipa Pharma to host conference call
Premium
The Fly
Hookipa Pharma to host conference call
4M ago
HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting
Premium
Press Releases
HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100